These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? Naresh KN; Raphael M; Ayers L; Hurwitz N; Calbi V; Rogena E; Sayed S; Sherman O; Ibrahim HA; Lazzi S; Mourmouras V; Rince P; Githanga J; Byakika B; Moshi E; Durosinmi M; Olasode BJ; Oluwasola OA; Akang EE; Akenòva Y; Adde M; Magrath I; Leoncini L Br J Haematol; 2011 Sep; 154(6):696-703. PubMed ID: 21707579 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Barrena S; Almeida J; Del Carmen García-Macias M; López A; Rasillo A; Sayagués JM; Rivas RA; Gutiérrez ML; Ciudad J; Flores T; Balanzategui A; Caballero MD; Orfao A Histopathology; 2011 May; 58(6):906-18. PubMed ID: 21438908 [TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification. Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291 [TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists. Cabrera ME; Martinez V; Nathwani BN; Muller-Hermelink HK; Diebold J; Maclennan KA; Armitage J; Weisenburger DD Leuk Lymphoma; 2012 Jul; 53(7):1311-7. PubMed ID: 22263570 [TBL] [Abstract][Full Text] [Related]
10. Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases. Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD Br J Haematol; 2016 Mar; 172(5):699-708. PubMed ID: 26684877 [TBL] [Abstract][Full Text] [Related]
11. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes. Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739 [TBL] [Abstract][Full Text] [Related]
12. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study. Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619 [TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project. Perry AM; Perner Y; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD Br J Haematol; 2016 Mar; 172(5):716-23. PubMed ID: 26898194 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype. Abuamsha H; Kadri AN; Hernandez AV Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804 [TBL] [Abstract][Full Text] [Related]
15. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946 [TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of patients with non-hodgkin lymphoma in Arnau de Vilanova Hospital, Valencia, Spain]. Monzó Castellano E; Morales Suárez-Varela M; Mayans Ferrer J; Vila López V An Med Interna; 2001 Dec; 18(12):629-34. PubMed ID: 11852498 [TBL] [Abstract][Full Text] [Related]
18. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma. Rossi C; Jégu J; Mounier M; Dandoit M; Colonna M; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Bouvier V; Woronoff AS; Monnereau A; Casasnovas O; Velten M; Troussard X; Maynadié M Leuk Lymphoma; 2015; 56(10):2876-82. PubMed ID: 25641432 [TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India. Manipadam MT; Nair S; Viswabandya A; Mathew L; Srivastava A; Chandy M World J Pediatr; 2011 Nov; 7(4):318-25. PubMed ID: 21633853 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]